Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactors.
暂无分享,去创建一个
S. Rosenberg | R. Knazek | P. Aebersold | S A Rosenberg | R A Knazek | Y W Wu | P M Aebersold | Y. W. Wu
[1] S. Rosenberg,et al. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. , 1986, Science.
[2] W. M. Linehan,et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. , 1987, The New England journal of medicine.
[3] P. Gullino,et al. Cell Culture on Artificial Capillaries: An Approach to Tissue Growth in vitro , 1972, Science.
[4] W. Linehan,et al. Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] W. Kidwell. Filtering Out Inhibition , 1989, Bio/Technology.
[6] S. Rosenberg. The Development of New Immunotherapies for the Treatment of Cancer Using Interleukin‐2: A Review , 1988, Annals of surgery.
[7] P. Gullino,et al. Hormone production by cells grown in vitro on artificial capillaries. , 1974, Experimental cell research.
[8] S. Rosenberg,et al. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. , 1987, Journal of immunological methods.
[9] S. Rosenberg,et al. Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma , 1988, The Journal of experimental medicine.
[10] S. Rosenberg,et al. Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy. , 1986, Journal of immunological methods.
[11] A. Belldegrun,et al. Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes. , 1989, Journal of immunology.
[12] S. Rosenberg,et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. , 1988, The New England journal of medicine.